Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo M, Avcin T, Bertolaccini M, Branch D, Jesus G, Devreese K, Frances C, Garcia D, Guillemin F, Levine S, Levy R, Lockshin M, Ortel T, Seshan S, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D, Agmon‐Levin N, Aguilar C, Alba P, Alpan O, Ambrozic A, Amoura Z, Andrade D, Andrade L, Appenzeller S, Esen B, Atsumi T, Berkun Y, Cabral A, Canaud G, Cervera R, Chen P, Chighizola C, Cimaz R, Cohen H, Costedoat‐Chalumeau N, Crowther M, Cuadrado M, de Groot P, de Moerloose P, Derksen R, Diz‐Kucukkaya R, Dörner T, Fortin P, Giannakopoulos B, Gómez‐Puerta J, Gonzalez E, Inanc M, Kenet G, Khamashta M, Kriegel M, Krilis S, Laskin C, Massicotte P, McCarty G, Meroni P, Mikdashi J, Myones B, Pengo V, Petri M, Roubey R, Sammaritano L, Sanna G, Sciascia S, Signorelli F, Soybilgic A, Tincani A, Woller S, Yelnik C. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis Care & Research 2021, 73: 1490-1501. PMID: 33253499, PMCID: PMC8966711, DOI: 10.1002/acr.24520.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements